logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Jack W Fisher

This inventor holds 9 USPTO granted patents and 2 published patent applications. Top assignee: Eli Lilly and Company. Active years: 1980-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jack W Fisher. Retrieved from https://idiyas.com/inventor/jack-w-fisher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal9 out of 4,514 
 
Eli Lilly and Company
 patents

Years Active: 1980-1997

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5700933 - Chiral intermediates for the preparation of carbacephems (1997-12-23),
2. 5644051 - Intermediates for the preparation of carbacephems (1997-07-01),
3. 5521307 - Methods and compounds for the preparation of carbacephems (1996-05-28),
4. 5302711 - Ester cleavage process for use with .beta.-lactams (1994-04-12),
5. 4271305 - Thiazolinoazetidinones and process therefor (1981-06-02),
6. 4237279 - Crystalline 3-hydroxycephalosporin solvates (1980-12-02),
7. 4230644 - Halogenating reagents (1980-10-28),
8. 4226986 - Process for halogenation of .beta.-lactam compounds (1980-10-07),
9. 4211702 - Process for preparation of penicillin and cephalosporin imino halides (1980-07-08),

Title: Inventor Spotlight: Jack W. Fisher

Introduction

Jack W. Fisher is a notable inventor based in Indianapolis, IN, recognized for his contributions to the field of pharmaceuticals. With a strong portfolio of nine patents, he has made significant advancements in the development of antimicrobial agents.

Latest Patents

One of Jack's latest patents involves "Chiral intermediates for the preparation of carbacephems," where he has developed azetidinone compounds that serve as intermediates for carbacephalosporins, which are useful as antibacterials. Another important patent is titled "Intermediates for the preparation of carbacephems," focusing on the synthesis of carbacephems and the methods related to their preparation. In this invention, the compounds are characterized by various structural formulas, including a wide range of organic groups such as phenyl and alkoxyphenyl derivatives.

Career Highlights

Jack W. Fisher is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative medical solutions. His work has not only advanced the company's research capabilities but has also contributed to significant breakthroughs in antibacterial therapies.

Collaborations

Throughout his career, Jack has collaborated with esteemed colleagues, including Lowell D. Hatfield and Larry C. Blaszczak. These partnerships have fostered a creative environment that has led to successful patent applications and innovative solutions in the pharmaceutical industry.

Conclusion

Jack W. Fisher's inventive spirit and collaborative work have positioned him as a significant figure in the pharmaceutical industry. With nine patents to his name and ongoing contributions to healthcare, he continues to inspire future innovations in antimicrobial therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…